SCHEMBL2909936

SCHEMBL2909936

CC[CH]CCCCOC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2955465 0.97 LPAR2 (0.38)
SCHEMBL4448550 0.83 ALDH1A1 (0.42)
SCHEMBL7181609 0.83 ALDH1A1 (0.42)
SCHEMBL9085008 0.82 LPAR3 (0.34)
SCHEMBL2389136 0.80
SCHEMBL8705724 0.80 TSHR (0.42)
SCHEMBL11203071 0.80 TSHR (0.33)
SCHEMBL9186856 0.78 ALDH1A1 (0.33)
SCHEMBL19259382 0.78 ALDH1A1 (0.33)
SCHEMBL8440343 0.77 ALDH1A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014037381-A1 METHOD FOR TREATING PRURITUS EURO-CELTIQUE S.A. (LU) 2014-03-13 WO disclosed
EP-2225246-A1 BENZOMORPHAN COMPOUNDS Purdue Pharma LP (US) 2010-09-08 EP disclosed
WO-2009068989-A1 BENZOMORPHAN COMPOUNDS PURDUE PHARMA L.P. (DE) 2009-06-04 WO disclosed
US-5880146-A INTERLEUKINS AND IMMUNOLOGY FOR AUTOIMMUNE DISEASES FUJI IMMUNOPHARMACEUTICALS CORPORATION (US) 1999-03-09 US disclosed
EP-0170624-B1 2,4,6-TRIFUNCTIONALIZED PHENOLS CIBA-GEIGY AG (CH) 1988-01-07 EP disclosed